Best Businesses In Town!
Tuesday, March 8, 2016
FDA Concedes Defeat on Off-Label Drug Marketing
(MedPage Today) -- Amarin can market its fish-oil product (Vascepa) for unapproved indications
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment